Ricky Lakhani
Chief Product Officer, PHARMASEAL
Key Points
- Integration in clinical trials is essential for efficiency
- Disconnected systems lead to data silos and inefficiencies
- Timely data visibility is crucial for effective trial management
- Quality by design principles should guide clinical research
- Partnerships can enhance integration and data sharing
- Data duplication can significantly impact trial timelines
- A mindset shift towards data utilisation is necessary for progress
Ricky Lakhani discusses the integration of technology in clinical trials, focusing on the challenges posed by disconnected systems, the importance of timely data, and the need for collaboration among teams. Tom and Ricky emphasise the significance of quality by design and the necessity for organisations to adapt to new technologies while maintaining a balance between standardisation and flexibility.
The conversation also highlights the integration partnership recently announced by Mayet and PHARMASEAL, as a value driver for their clients.
Chapters
About the Guest
Ricky Lakhani
Chief Product Officer, PHARMASEAL
Ricky is a product management expert with 20 years of experience in life sciences and technology. He has led the development of innovative software solutions that improve clinical trial execution, holding key roles at Amgen, Roche, and Medidata. Known for bridging scientific rigor with technical strategy, Ricky has a strong track record of turning complex challenges into scalable, user-focused products.
His leadership has consistently driven product innovation, operational efficiency, and business growth across the clinical research landscape.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.